84 related articles for article (PubMed ID: 36529521)
1. A feedback loop between NONHSAT024276 and PTBP1 inhibits tumor progression and glycolysis in HCC by increasing the PKM1/PKM2 ratio.
Li Y; Chen X; Huang H; Liao L; Chong H; Li G; Yuan T; Lu W; Deng S; Huang Q
Cancer Sci; 2023 Apr; 114(4):1519-1540. PubMed ID: 36529521
[TBL] [Abstract][Full Text] [Related]
2. LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement.
Zhang C; Wang H; Liu Q; Dai S; Tian G; Wei X; Li X; Zhao L; Shan B
J Exp Clin Cancer Res; 2023 Sep; 42(1):246. PubMed ID: 37740243
[TBL] [Abstract][Full Text] [Related]
3. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2.
Yu-Ying C; Qian Z; Meng-Hui G; Lan F; Peng-Bo C; Gang-Qiao Z
Yi Chuan; 2024 Jan; 46(1):46-62. PubMed ID: 38230456
[TBL] [Abstract][Full Text] [Related]
4. [RBMX overexpression inhibits proliferation, migration, invasion and glycolysis of human bladder cancer cells by downregulating PKM2].
Yan Q; Zeng P; Huang S; Tan C; Zhou X; Qiao J; Zhao X; Feng L; Zhu Z; Zhang G; Hu H; Chen C
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):9-16. PubMed ID: 38293971
[TBL] [Abstract][Full Text] [Related]
5. A novel LINC00478 serves as a tumor suppressor in endometrial carcinoma progression.
Feng Y; Dong Y; Rao B; Yu Y; Su W; Zeng J; Zhao E; Chen Y; Fang S; Zhou Y; Lu J; Qiu F
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14927-14940. PubMed ID: 37603104
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity.
Fei M; Li X; Liang S; Zhou S; Wu H; Sun L; Liu Y; Hu Q; Liu L; Wang J
Cancer Lett; 2024 Mar; 584():216620. PubMed ID: 38218456
[TBL] [Abstract][Full Text] [Related]
7. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis.
Gao S; Wang Y; Xu Y; Liu L; Liu S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167011. PubMed ID: 38176460
[TBL] [Abstract][Full Text] [Related]
8. N
Ji X; Liu Z; Gao J; Bing X; He D; Liu W; Wang Y; Wei Y; Yin X; Zhang F; Han M; Lu X; Wang Z; Liu Q; Xin T
Cell Death Differ; 2023 Jan; 30(1):54-68. PubMed ID: 35871232
[TBL] [Abstract][Full Text] [Related]
9. Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation.
Zeng Y; Jiang H; Zhang X; Xu J; Wu X; Xu Q; Cai W; Ying H; Zhou R; Ding Y; Ying K; Song X; Chen Z; Zeng L; Zhao L; Yu F
Free Radic Biol Med; 2023 Nov; 208():571-586. PubMed ID: 37696420
[TBL] [Abstract][Full Text] [Related]
10. The Regulatory Network of hnRNPs Underlying Regulating
Li Y; Zhang S; Li Y; Liu J; Li Q; Zang W; Pan Y
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785973
[TBL] [Abstract][Full Text] [Related]
11. Non-metabolic enzyme function of PKM2 in hepatocellular carcinoma: A review.
Zhang S; Liao Z; Li S; Luo Y
Medicine (Baltimore); 2023 Oct; 102(42):e35571. PubMed ID: 37861491
[TBL] [Abstract][Full Text] [Related]
12. Base editing-mediated perturbation of endogenous PKM1/2 splicing facilitates isoform-specific functional analysis in vitro and in vivo.
Lin J; Wu S; Shen Q; Liu J; Huang S; Peng G; Qiao Y
Cell Prolif; 2021 Aug; 54(8):e13096. PubMed ID: 34240779
[TBL] [Abstract][Full Text] [Related]
13. Positioning determines function: Wandering PKM2 performs different roles in tumor cells.
He S; Liang Y; Tan Y; Liu Q; Liu T; Lu X; Zheng S
Cell Biol Int; 2024 Jan; 48(1):20-30. PubMed ID: 37975488
[TBL] [Abstract][Full Text] [Related]
14. The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues.
Li L; Cheng S; Yeh Y; Shi Y; Henderson N; Price D; Gu X; Yu X
bioRxiv; 2024 Jan; ():. PubMed ID: 38260443
[TBL] [Abstract][Full Text] [Related]
15. The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues.
Li L; Cheng S; Yeh Y; Shi Y; Henderson N; Price D; Gu X; Yu X
Front Oncol; 2024; 14():1392085. PubMed ID: 38680860
[TBL] [Abstract][Full Text] [Related]
16. Serine/Arginine-Rich Splicing Factor 7 Knockdown Inhibits Aerobic Glycolysis and Growth in HepG2 Cells by Regulating PKM2 Expression.
Shi W; Yao X; Cao X; Fu Y; Wang Y
Curr Issues Mol Biol; 2024 May; 46(5):5023-5036. PubMed ID: 38785569
[TBL] [Abstract][Full Text] [Related]
17. Muscle-Specific Pyruvate Kinase Isoforms, Pkm1 and Pkm2, Regulate Mammalian SWI/SNF Proteins and Histone 3 Phosphorylation During Myoblast Differentiation.
Olea-Flores M; Sharma T; Verdejo-Torres O; DiBartolomeo I; Thompson PR; Padilla-Benavides T; Imbalzano AN
bioRxiv; 2024 Apr; ():. PubMed ID: 38645038
[TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of metabolic enzyme PKM2 participates in high glucose-promoted HCC metastasis by strengthening immunosuppressive environment.
Qian J; Huang C; Wang M; Liu Y; Zhao Y; Li M; Zhang X; Gao X; Zhang Y; Wang Y; Huang J; Li J; Zhou Q; Liu R; Wang X; Cui J; Yang Y
Redox Biol; 2024 May; 71():103103. PubMed ID: 38471282
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8
Gao Y; Gong Y; Lu J; Yang Y; Zhang Y; Xiong Y; Shi X
Biochem Pharmacol; 2024 May; 225():116294. PubMed ID: 38754557
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation.
Lunt SY; Muralidhar V; Hosios AM; Israelsen WJ; Gui DY; Newhouse L; Ogrodzinski M; Hecht V; Xu K; Acevedo PN; Hollern DP; Bellinger G; Dayton TL; Christen S; Elia I; Dinh AT; Stephanopoulos G; Manalis SR; Yaffe MB; Andrechek ER; Fendt SM; Vander Heiden MG
Mol Cell; 2015 Jan; 57(1):95-107. PubMed ID: 25482511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
